Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Giles_Jon_NY_web.jpg)
Much still unknown about inflammation’s role in RA patients’ CVD risk
- Author:
- Sharon Worcester
CVD risk remains elevated in RA patients, and data increasingly highlight the role of inflammation and its...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/138262_Maziarz_Richard_web.jpg)
Midostaurin maintenance may reduce relapse risk in FLT3-ITD+ AML
- Author:
- Sharon Worcester
HOUSTON – The effect was most pronounced in those with high pFLT3 inhibition on plasma inhibitor activity assay.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Imus_PhilipH_BALTIMORE_web.jpg)
AlloBMT should be option for older adults with hematologic malignancies
- Author:
- Sharon Worcester
HOUSTON – Allogeneic BMT should not be denied in older adults with hematologic malignancies based on age alone.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/ChristopherStine_Lisa_BALT_web.jpg)
Dr. Lisa Christopher-Stine: Polymyositis? It’s more likely something else
- Author:
- Sharon Worcester
Thinking polymyositis? Look closely for IMNM, overlap with other rheumatologic conditions, antisynthetase syndrome, inclusion body myositis, and...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Giles_Jon_NY_web.jpg)
Take action to mitigate CVD risk in RA patients
- Author:
- Sharon Worcester
The mechanisms of increased CVD risk in RA are multifactorial, and risk management strategies should take into account a patient’s apparent risk,...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/137680_Maude_Shannon_web.jpg)
PD-1 blockade plus CD19 CAR T boosts CAR T-cell persistence
- Author:
- Sharon Worcester
SAN DIEGO – The combination appears to bolster CAR T-cell effects and persistence in children with relapsed B-ALL.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/breast_implants_office_web.jpg)
FDA: 246 new reports on breast implant-associated lymphoma
- Author:
- Sharon Worcester
The latest update from the Food and Drug Administration includes medical device reports between September 2017 and September 2018.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Pisetsky_David_NC2_web.jpg)
New findings raise questions about the role of ANAs in SLE
- Author:
- Sharon Worcester
Studies suggest that 20%-30% of SLE patients are ANA negative at testing and that there is a great deal of variability across tests, which could...
News
Enoblituzumab plus pembrolizumab shows promise for select solid tumors
- Author:
- Sharon Worcester
WASHINGTON – Combination enoblituzumab and pembrolizumab showed acceptable safety and encouraging antitumor activity in select patients with B7-H3...
Article
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/April-2018/Gold_Mark_Fla_web.jpg)
Rise in HCV infection rates linked to OxyContin reformulation
- Author:
- Sharon Worcester
An effort to deter opioid abuse – namely the 2010 abuse-deterrent reformulation of OxyContin – appears to have fueled a sharp increase in HCV...
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
The personal cancer vaccine NEO-PV-01 shows promise in metastatic cancers
- Author:
- Sharon Worcester
WASHINGTON – The NEO-PV-1 neoantigen vaccine plus poly-ICLC adjuvant and nivolumab is well tolerated and shows clinical activity in metastatic...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Breast_cancer_surgery_scars_web.jpg)
Single-cell genomics drive progress toward human breast cell atlas development
- Author:
- Sharon Worcester
SAN ANTONIO – Improved understanding of the cellular landscape of both normal breast tissue and breast cancer could...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Veale_Douglas_J_DUBLIN_web.jpg)
Findings in seropositive arthralgia patients may help to predict RA
- Author:
- Sharon Worcester
Evidence hints that targets of immune checkpoint inhibitor therapy may play role in RA risk.
News
GALLIUM: MRD response correlates with outcomes in follicular lymphoma
- Author:
- Sharon Worcester
SAN DIEGO – MRD response at the end of induction correlates with outcomes in previously untreated follicular lymphoma patients receiving...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Weinblatt_Michael_E_MASS_web.jpg)
Experts cite different approaches to try for methotrexate-related nausea, fatigue
- Author:
- Sharon Worcester
Arthritis expert panel: A few different approaches can help address methotrexate-related nausea and fatigue, which is important to prevent...